Mirati Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

65,534

Value ($000)

3,850

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	3,850	0.0%	65,534	12/31/2023
2023 Q3	11/13/2023	12,989	0.0%	298,194	9/30/2023
2023 Q2	8/11/2023	11,259	0.0%	302,821	6/30/2023
2023 Q1	5/15/2023	11,259	0.0%	302,821	3/31/2023
2022 Q4	2/14/2023	10,870	0.0%	239,902	12/31/2022
2022 Q3	11/14/2022	14,103	0.0%	201,926	9/30/2022
2022 Q2	8/12/2022	14,595	0.0%	217,419	6/30/2022
2022 Q1	5/16/2022	23,651	0.0%	287,660	3/31/2022
2021 Q4	2/14/2022	78,489	0.0%	535,065	12/31/2021
2021 Q3	11/15/2021	72,002	0.0%	407,000	9/30/2021
2021 Q2	8/16/2021	69,579	0.0%	430,751	6/30/2021
2021 Q1	5/14/2021	79,499	0.0%	464,090	3/31/2021
2020 Q4	3/1/2021	108,066	0.1%	492,016	12/31/2020
2020 Q3	11/13/2020	107,317	0.1%	646,296	9/30/2020
2020 Q2	8/14/2020	69,033	0.0%	604,650	6/30/2020
2020 Q1	5/15/2020	46,004	0.0%	598,463	3/31/2020
2019 Q4	2/14/2020	46,974	0.0%	364,532	12/31/2019